<unk> , sold by Merck & Co., Inc. (USA) under the brand name Bridion, is a medication for the reversal of neuromuscular blockade induced by rocuronium and vecuronium in general anaesthesia. It is the first selective relaxant binding agent (SRBA). The most common side effects include cough, airway problems due to the anaesthesia wearing off, reduced blood pressure and other complications such as changes in heart rate.
Sugammadex
Eptazocine
Pentazocine
Iopentol
Fomepizole
Etomidate
Neostigmine
Bremazocine